FDA Accepts Supplemental Biologics License Application for Roche’s Polivy Combination for People with Previously Untreated Diffuse Large B-cell Lymphoma
First new treatment regimen in more than 20 years to significantly improve outcomes in people with this fast-growing type of lymphoma Application is based on pivotal data from the phase… Read More



